Enhanced peripheral nerve regeneration through asymmetrically porous nerve guide conduit with nerve growth factor gradient. 2018

Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
Department of Nanobiomedical Science, Dankook University, Cheonan, 31116, Republic of Korea.

In this study, we fabricated a nerve guide conduit (NGC) with nerve growth factor (NGF) gradient along the longitudinal direction by rolling a porous polycaprolactone membrane with NGF concentration gradient. The NGF immobilized on the membrane was continuously released for up to 35 days, and the released amount of the NGF from the membrane gradually increased from the proximal to distal NGF ends, which may allow a neurotrophic factor gradient in the tubular NGC for a sufficient period. From the in vitro cell culture experiment, it was observed that the PC12 cells sense the NGF concentration gradient on the membrane for the cell proliferation and differentiation. From the in vivo animal experiment using a long gap (20 mm) sciatic nerve defect model of rats, the NGC with NGF concentration gradient allowed more rapid nerve regeneration through the NGC than the NGC itself and NGC immobilized with uniformly distributed NGF. The NGC with NGF concentration gradient seems to be a promising strategy for the peripheral nerve regeneration. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 52-64, 2018.

UI MeSH Term Description Entries
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D009416 Nerve Regeneration Renewal or physiological repair of damaged nerve tissue. Nerve Tissue Regeneration,Nervous Tissue Regeneration,Neural Tissue Regeneration,Nerve Tissue Regenerations,Nervous Tissue Regenerations,Neural Tissue Regenerations,Regeneration, Nerve,Regeneration, Nerve Tissue,Regeneration, Nervous Tissue,Regeneration, Neural Tissue,Tissue Regeneration, Nerve,Tissue Regeneration, Nervous,Tissue Regeneration, Neural
D011091 Polyesters Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. Polyester
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D000073396 Metal-Organic Frameworks Supramolecular networks that consist of ordered arrangements of organic electron donor linkers (usually ditopic or polytopic organic carboxylates) and metal cations. They can have an extremely high surface area and adjustable pore size that allows for the insertion of other molecules capable of various functions such as catalysis, capture of carbon dioxide, and drug delivery. Metal Organic Framework,Metal-Organic Framework,Porous Coordination Polymer,Covalent Organic Framework,Porous Coordination Networks,Porous Coordination Polymers,Coordination Networks, Porous,Coordination Polymer, Porous,Coordination Polymers, Porous,Framework, Covalent Organic,Framework, Metal Organic,Framework, Metal-Organic,Frameworks, Metal-Organic,Metal Organic Frameworks,Networks, Porous Coordination,Organic Framework, Covalent,Organic Framework, Metal,Polymer, Porous Coordination,Polymers, Porous Coordination
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012584 Sciatic Nerve A nerve which originates in the lumbar and sacral spinal cord (L4 to S3) and supplies motor and sensory innervation to the lower extremity. The sciatic nerve, which is the main continuation of the sacral plexus, is the largest nerve in the body. It has two major branches, the TIBIAL NERVE and the PERONEAL NERVE. Nerve, Sciatic,Nerves, Sciatic,Sciatic Nerves

Related Publications

Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
December 2013, Tissue engineering. Part A,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
April 2008, Biomaterials,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
August 2010, Journal of biomedical materials research. Part B, Applied biomaterials,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
May 2014, Journal of tissue engineering and regenerative medicine,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
January 2014, Thyroid : official journal of the American Thyroid Association,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
December 2023, Journal of biomedical materials research. Part A,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
June 1993, Lymphokine and cytokine research,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
January 1993, Journal of Tongji Medical University = Tong ji yi ke da xue xue bao,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
March 2013, Tissue engineering. Part C, Methods,
Se Heang Oh, and Jun Goo Kang, and Tae Ho Kim, and Uk Namgung, and Kyu Sang Song, and Byeong Hwa Jeon, and Jin Ho Lee
January 1990, ASAIO transactions,
Copied contents to your clipboard!